Study of Clinical and Laboratory Variables Associated With a Direct Oral Anticoagulant Bioassay Higher Among Those Aged Over 75 Years (AOD-SA)

Nantes University Hospital (NUH)

Status: Completed

Conditions: Atrial Fibrillation

Treatments: Other: blood test

Study type: Observational

Funder types: Other

Identifiers

NCT02894450

RC14_0402

Details and patient eligibility

About

The objective of this study was to investigate whether there is a link between clinical and biological variables and bioassay high xaban in elderly patients as part of an unscheduled hospitalization.

Enrollment: 70 patients

Sex: All

Ages: 75+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Age ≥ 75 years
• Entering SAU or MPG (Nantes University Hospital) as part of an unscheduled hospitalization for acute or subacute disease (About MPG, will be included patients admitted to the department within 48 hours of calling the doctor)
• In xaban to entry (dabigatran, rivaroxaban, Apixaban) for non-valvular atrial fibrillation
• In whom hemostasis tests will be prescribed as part of usual care
• Patient has given its verbal agreement

Exclusion criteria

Patients with the following criteria may not be included:

• Patients refusing to participate in the study
• Patients under guardianship
• Inability to obtain the date and time of the last dose of xaban